findmyKOL
Clinical trialNCT06628570RecruitingInterventional

Screening Strategies Among High-risk Populations for Anal Cancer

SponsorLisa FlowersEnrollment500HPV-Related Anal Squamous Cell CarcinomaNeoplasms
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic response, and environmental factors associated with aHSIL.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida, United States

    Isabella Rosa-Cunah, MD
    Recruiting
  • University of Miami School of Medicine at Jackson Memorial Hospital (jmh)

    Miami, Florida, United States

    Isabella Rosa-Cunha, MD
    Recruiting
  • Grady Memorial Hospital

    Atlanta, Georgia, United States

    Recruiting
  • the Ponce Center

    Atlanta, Georgia, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Dec 2024
Primary completion
31 Oct 2027
Completion
31 Oct 2027
Last update posted
8 Sept 2025
Registered enrollment
500
Registry id
NCT06628570
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.